Summary & Overview
HCPCS Level II J7638: Dexamethasone Inhalation Solution, Compounded
HCPCS Level II code J7638 denotes a compounded inhalation solution of dexamethasone provided in unit-dose form and billed per milligram for administration via durable medical equipment. This code matters nationally as it captures billing for a specialized compounded respiratory steroid delivered through nebulizers or similar DME, relevant for patients requiring inhaled corticosteroid therapy when standard formulations are unsuitable.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what J7638 represents, the clinical context for inhaled dexamethasone compounded products, typical sites of service (home and outpatient DME-based administration), and the types of benchmarks and policy considerations that commonly accompany drug-as-DME billing. The publication outlines common modifiers used with this code and touchpoints for prior authorization, coverage variability, and billing compliance considerations.
The piece provides national-level context rather than state-specific rules, and identifies areas where payer policies and reimbursement practices often differ for compounded inhalation products administered through DME. Data not available in the input will be noted where applicable.
Billing Code Overview
HCPCS Level II code J7638 represents dexamethasone, inhalation solution, compounded product, administered through durable medical equipment (DME), unit dose form, per milligram. This code describes a compounded inhalation formulation of dexamethasone intended for aerosolized delivery using DME such as a nebulizer.
-
Service type: Drug administration via DME (inhalation solution compounded, unit-dose, per mg)
-
Typical site of service: Home or outpatient settings where durable medical equipment is used for inhalation therapy, including patient residence when DME is utilized and outpatient infusion or respiratory therapy clinics.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult or pediatric patient with acute or chronic airway inflammation or laryngotracheal edema requiring nebulized corticosteroid therapy delivered via durable medical equipment (DME) such as a nebulizer. For example, a patient with severe asthma exacerbation or post-extubation laryngeal edema presents to an outpatient infusion clinic or emergency department and is prescribed nebulized dexamethasone formulated as a compounded inhalation solution. The pharmacy compounds unit-dose vials of J7638 per milligram concentration and the medication is administered through facility DME by a respiratory therapist or trained nurse.
The clinical workflow: the prescriber documents indication and dose, pharmacy compounds the unit-dose inhalation solution labeled with milligram content, the patient is brought to the treatment area with DME (nebulizer) set up, staff verify identity and allergies, administer the inhaled dexamethasone via nebulizer, monitor vital signs and response, document administration (medication, dose in mg, lot number, route inhalation, and staff credentials), and bill the compound product using J7638 with appropriate modifiers and associated facility or outpatient visit codes as applicable.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 |